Uncategorized

Earth Science Tech, Inc. (ETST) Achieves Highest Sales Revenue Month of February

DORAL, FL March 14, 2018 via (GLOBE NEWSWIRE) – Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, as well as on R&D for certain medical devices, today announces highest sales revenue month of February.

 

As anticipated, February the Company achieved the highest sales revenue month with sales of $75,981.02 a 90% revenue increase compared to last year’s $39,881.99 February 2017. This achievement is due to the Company’s new veteran Chief Sales Officer, (CSO) and revamp CBD line. March has already started strong and is headed to be high revenue month leading to the Company’s highest revenue fiscal year.

 

Jill Buzan, ETST’s CSO states, “my first month with the company has been an amazing experience with so much potential. I’m excited to see that we were able to achieve the highest revenue month to date, especially due to product delivery delays and slight errors made from the manufacture. Starting the month of March with our full inventory and all errors corrected we’ll be able to truly take Earth Science Tech, Inc. to new heights.”

 

The Company’s President, Director, & COO ends with, “February looked to be our pivotal month having the honor of having Jill Buzan as our CSO, transitioning Gabriel Aviles to our Chief Learning Officer, (CLO), and our new revamped CBD line. Jill Buzan has brought so much to our company, with her experience and knowledge Earth Science Tech, Inc. truly looks to stay innovative and be the trusted CBD brand in the industry. Gabriel Aviles has started recored live one hour videos from Monday to Friday from 1pm-2pm on our youtube channel and his videos will start being shared throughout social media. Our new product revamp has been successful despite the manufacturing delays and minor errors due to the increasing product demand leading us to rush the process. We are already working on our next batch improving our essential oils, providing our manufacture to have time to eliminate any potential errors and preventing backorders.”

 

Mr. Tabraue continues, “our audit continues to move forward and looks to be finalized within the month of March and be used to submit our planned Tier II Regulation A+ as well our planned OTCQB up-listing. The team and I greatly appreciate our stakeholder’s loyalty, trust, and support while growing with us. We plan on sharing updates as they progress.”

 

About Earth Science Tech, Inc. (ETST)

Earth Science Tech has among the highest quality, purity and full-spectrum high-grade hemp CBD (cannabidiol) oil on the market. Made using the superior supercritical CO2 liquid extraction, ETST’s CBD oil is 100% natural and organic. The company’s research, performed alongside the University of Central Oklahoma and DV Biologics laboratory, demonstrates that ETST is the top nutritional and dietary supplement brand for high-grade hemp CBD oil.

To learn more and to buy CBD Hemp Oil, please visit: www.EarthScienceTech.com

About Earth Science Pharmaceutical

Earth Science Pharmaceutical, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc (ETST). Earth Science Pharmaceutical is focused on becoming a world leader in the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for STIs (sexually transmitted infections and/or diseases). Earth Science Pharmaceutical CEO Dr. Michel Aubé, a renowned scientist, is committed to help grow ETST in the medical and pharmaceutical industry.

To learn more please visit: www.EarthSciencePharmaceutical.com

About Cannabis Therapeutics

Cannabis Therapeutics, Inc. is a wholly owned subsidiary of Earth Science Tech, Inc. (ETST). Cannabis Therapeutics was formed as an emerging biotechnology company poised to become a world leader in cannabinoid research and development for a broad line of cannabis cannabinoid-based pharmaceuticals, nutraceuticals, as well as other products & solutions. Cannabis Therapeutics’ mission it to help change the health care landscape by introducing its proprietary cannabis-cannabinoid-based products made for both the pharmaceutical and retail consumer markets worldwide.

To learn more please visit: www.CannabisThera.com

About KannaBidioiD

KannaBidioid, Inc. is wholly owned subsidiary of Earth Science Tech, Inc. (ETST). KannaBidioid is focused in the recreational space to manufacture and distribute vapes/e-liquids and gummy edibles in the recreational space formulated by its unique Kanna and CBD formula. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhance focus, and help with nicotine addiction based on their properties.

To learn more please visit: www.KannaBidioiDInc.com

SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations Contact:

Dave Demarest

305.546.7640 Office

 

Company Contact:

www.EarthScienceTech.com

Nickolas S. Tabraue

President, Director, Chief Operating Officer

305.615.2118 Office